| Autor: |
Ribrag V; Département de Médecine, Institut Gustave Roussy, Villejuif., Ghnassia M, Théodore C, Ghosn M, Piot G, Beurton D, Cukier J, Droz JP |
| Jazyk: |
francouzština |
| Zdroj: |
Journal d'urologie [J Urol (Paris)] 1990; Vol. 96 (7), pp. 373-4. |
| Abstrakt: |
Between January 1, 1983 and December 31, 1984, 18 patients with advanced transitional cell carcinoma of the urothelium were treated in a Phase II trial with doxorubicin 45 mg/sqm plus cisplatin 90/mg/sqm/day every four weeks. 17 patients were evaluable for response. There were: 4 partial responses (24% of response objective effects, 95% confidence limits are 15% and 33%) and 13 failures. The median survival was 18.5 months for responders and 10 months for non responders. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
